Injective’s token, INJ, is currently trading at around $12.22 after experiencing a -2.6% daily decline and a -3.5% weekly pullback. However, the token still holds a strong +38.3% increase year-over-year and maintains its #112 global market ranking with a high trading volume of $76.9 million. 678,000 INJ were recently acquired by Pineapple Financial, signaling growing institutional interest and significant capital deployment within the Injective ecosystem. Injective’s expansion includes partnerships with Kado, Helix, and Eclipse Labs to bolster liquidity aggregation across multiple chains. Notably, Pineapple Financial, in a major strategic move, purchased 678,000 INJ for $8.9 million, establishing a $100 million Injective-based digital asset treasury. The token is currently consolidating within the range of $12.00-$12.80 before breaking out. However, a strong close above $12.90 could trigger an upward movement towards $13.50-$14.00. The overall market sentiment remains neutral, as evidenced by the RSI’s near 48 reading and muted trading volume. Despite short-term weakness, the bullish macro trend is supported by strong on-chain metrics and institutional backing. Injective stands out for its ability to facilitate DeFi applications, derivatives markets, and interoperability across various chains like Ethereum, Solana, and Cosmos IBC. A recent development is the acquisition of INJ by Pineapple Financial, signaling a significant investment in the project.